Who
Shelia M. Violette
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Q32 Bio.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $131K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Mar 2024
- Last trade
- 6 Oct 2026
- Last filed
- 14 Oct 2026
Companies traded
Activity over time
1 Aug 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 14 Oct 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Sold | $7,629917 at $8.32 | filing |
| 25 Aug 2026filed 27 Aug 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Sold | $46K2,798 at $16.56 | filing |
| 25 Aug 2026filed 27 Aug 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Sold | $46K2,798 at $16.56 | filing |
| 16 Jul 2026filed 20 Jul 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Sold | $13K2,815 at $4.51 | filing |
| 25 Feb 2026filed 27 Feb 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Sold | $13K2,815 at $4.51 | filing |
| 24 Feb 2026filed 20 Mar 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 24 Feb 2026filed 20 Mar 2026 | QTTB Q32 BioBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 26 Aug 2025filed 28 Aug 2025 | QTTB Q32 BioBiotechnology | SEC FORM 4 Sold | $5,3822,990 at $1.80 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —32,891 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —32,891 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —13,305 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —13,305 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —17,506 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —17,506 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —56,413 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —56,413 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 BioBiotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 15 Oct 2024filed 16 Oct 2024 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
News
Head to Head Review: Q32 Bio (NASDAQ:QTTB) vs. Applied Therapeutics (NASDAQ:APLT)QTTB · tickerreport.com · 15 Oct 2026Head to Head Review: Kyntra Bio (NASDAQ:KYNB) and Q32 Bio (NASDAQ:QTTB)QTTB · tickerreport.com · 12 Oct 2026Contrasting Q32 Bio (NASDAQ:QTTB) and Kyntra Bio (NASDAQ:KYNB)QTTB · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Shelia M. Violette; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.